- Special Sections
- Public Notices
Los Alamos National Laboratory (LANL) has selected Manhattan Isotopes Technology, LLC and Vista Therapeutics, Inc. as recipients of $100,000 awards from the Los Alamos National Security, LLC Venture Acceleration Fund.
The Venture Acceleration Fund (VAF) invests in innovative Northern New Mexico companies seeking to commercialize technology and take it to market faster.
VAF investments help the companies and their technologies reach the next level of success through business development activities such as proof-of-concept, prototyping, securing initial customers, or additional funding. Projects with an association with LANL technology or expertise receive preference for funding.
The VAF program fills a unique need by providing capital that reduces a company’s risk.
“Without this type of funding, projects can languish or take much longer to come to fruition,” says said David Pesiri, the Laboratory’s Technology Transfer Division leader.
“Our team also works closely with the companies during their contract period to connect them with other resources—like mentors, customers, and contacts—that will make them more successful in the long run.
Click the question mark below to see where your account ID appears on your mailing label.